Discover the history behind our areas of therapeutic expertise, patient-centric biosimilar development, state-of-the-art production, and rigorous testing.
Our commitment to deliver high-quality biosimilars is built on more than 100 years of expertise across numerous therapeutic areas. See what we have to offer today.
We strive to ease the healthcare burden with affordable biologic medicine. Learn more about our biosimilar products.
We power our operations with dedicated commercial teams in various disciplines such as R&D, manufacturing and supply chain management.
Learn about the analytical methods we use to assess drug characteristics for biosimilarity between the biosimilar candidate and the reference product.
Learn more about our approved biosimilar products in rheumatology, oncology, endocrinology, gastroenterology, and dermatology. Explore our biosimilars pipeline.
Our comprehensive portfolio of high-quality medicines has been developed with proven similarity in efficacy, safety, and immunogenicity to their reference products.
Learn about the indications, biosimilarity to Humira® (adalimumab), dosing & administration, and patient support options. View information for patients & caregivers.
Learn about the indications, biosimilarity to Xgeva® (denosumab), dosing & administration, and patient support options. View information for patients & caregivers.
Learn about the indications, biosimilarity to Prolia® (denosumab), dosing & administration, and patient support options. View information for patients & caregivers.
Learn about the indications, biosimilarity to Stelara® (ustekinumab), dosing & administration, and patient support options. View information for patients & caregivers.
Learn about the indication, biosimilarity to Neulasta®, dosing & administration and patient support options. View information for patients & caregivers.
Learn about TYENNE® (tocilizumab-aazg), the first FDA-approved biosimilar for Actemra® (tocilizumab) made by Fresenius Kabi. See safety, dosing, and full prescribing info.
View our pipeline of biosimilars in the areas of immunology, oncology, hematology and endocrinology.
See how we partner with healthcare providers and patients, and explore the benefits of our dedicated patient support program.
See who we work with to develop, manufacture and commercialize biosimilar products.
Our patient support program was developed with input from patients. Explore assistance options related to enrollment, insurance and therapy.
Download guides, watch our videos and discover useful links.
Search
You are now leaving the Biosimilars website.